RNA, U1 small nuclear 129, pseudogene (RNU1-129P)

RNA, U1 small nuclear 129, pseudogene (RNU1-129P) is a pseudogene related to U1 small nuclear RNA, which is a component of the spliceosome, involved in the recognition of 5’ splice sites and mRNA processing. However, as a pseudogene, RNU1-129P does not encode a functional snRNA product and is not involved in canonical U1-related biological functions. There are no known therapeutic uses, biological activities, disease associations, or drug interactions because pseudogenes, by definition, lack protein or functional RNA coding potential[1]. *Some confusion may exist due to overlap with functional small nuclear RNAs such as RNU1-1, but RNU1-129P itself is a non-functional pseudogene*. The functional U1 small nuclear RNA genes (e.g., RNU1-1) are essential for mRNA splicing and have been studied for therapeutic applications involving splicing defects[2][3][5]. Pseudogenes such as RNU1-129P generally are not considered molecular drug targets since they do not encode active products or participate in regulatory or catalytic pathways[1]. The query confuses the functional snRNA targets (like RNU1-1) with non-functional pseudogenes. In summary, RNU1-129P ("RNA, U1 small nuclear 129, pseudogene") is not a therapeutic target, is a non-functional pseudogene related to U1 snRNA, and has no known role in drug interaction or disease. This entry is likely a byproduct of gene duplication and loss of function and should not be considered a canonical therapeutic target[1].

Other names

RNU1-137PRNA, U1 small nuclear 137, pseudogeneRNU1-129P